SCHEMBL6566972

SCHEMBL6566972

CC(C)(C)c1cc(CCCCCCO)ccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 5/20 0.49
ALOX15 P16050 6/20 0.48
IGF1R P08069 5/20 0.48
ALDH1A1 P00352 2/20 0.47
NR1I2 O75469 1/20 0.47
LMNA P02545 1/20 0.47
CYP2C9 P11712 1/20 0.47
MIF P14174 1/20 0.47
TYR P14679 1/20 0.47
HTT P42858 1/20 0.47
NFE2L2 Q16236 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ACHE P22303 2/20 0.44
CDK1 P06493 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALOX5 P09917 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
BACE1 P56817 1/20 0.43
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568755 1.00 BCHE (0.49) BCHEALOX15IGF1RALDH1A1NR1I2
SCHEMBL6416102 0.98 ALOX15 (0.50) BCHEALOX15IGF1RALDH1A1NR1I2
SCHEMBL2913386 0.93 ALOX15 (0.50) BCHEALOX15IGF1RALDH1A1NR1I2
SCHEMBL9246524 0.88 ALOX15 (0.55) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL106675 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL107937 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL28387660 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL109409 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL8975192 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA
SCHEMBL994580 0.87 KAT8 (0.56) ALOX15IGF1RALDH1A1NR1I2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1572795-A Process for producing phosphite SUMITOMO CHEMICAL CO (JP) 2005-02-02 CN disclosed
EP-1484334-A2 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-08 EP disclosed
US-20040225145-A1 Process for producing phosphite SUMITOMO CHEMICAL COMPANY, LIMITED 2004-11-11 US disclosed
EP-0823435-B1 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL CO (JP) 2001-11-21 EP disclosed
US-6242514-B1 CYCLIC PHOSPHATE OR PHOSPHONATE; HEAT AND OXIDATION STABILIZER ESPECIALLY FOR OLEFIN POLYMERS AND ENGINEERING THERMOPLASTICS SUMITOMO CHEMICAL COMPANY, LTD. (JP) 2001-06-05 US disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040225145-A1 Process for producing phosphite PHOSPHO1, PLCG1, PLCG2 BCHE 1133/4885ALOX15 790/4885IGF1R 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.